• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用-评分来识别胆管癌的致癌途径。 需注意,这里原文中的“-score”表述不太完整准确,可能是有具体的评分名称未完整给出。

Utilizing -score to identify oncogenic pathways of cholangiocarcinoma.

作者信息

Hsiao Tzu-Hung, Chen Hung-I Harry, Lu Jo-Yang, Lin Pei-Ying, Keller Charles, Comerford Sarah, Tomlinson Gail E, Chen Yidong

机构信息

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

出版信息

Transl Cancer Res. 2013 Feb 1;2(1):6-17. doi: 10.3978/j.issn.2218-676X.2012.12.04.

DOI:10.3978/j.issn.2218-676X.2012.12.04
PMID:23905013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3725832/
Abstract

Extracting maximal information from gene signature sets (GSSs) via microarray-based transcriptional profiling involves assigning function to up and down regulated genes. Here we present a novel sample scoring method called Signature-score (S-score) which can be used to quantify the expression pattern of tumor samples from previously identified gene signature sets. A simulation result demonstrated an improved accuracy and robustness by S-score method comparing with other scoring methods. By applying the S-score method to cholangiocarcinoma (CAC), an aggressive hepatic cancer that arises from bile ducts cells, we identified enriched oncogenic pathways in two large CAC data sets. Thirteen pathways were enriched in CAC compared with normal liver and bile duct. Moreover, using S-score, we were able to dissect correlations between CAC-associated oncogenic pathways and Gene Ontology function. Two major oncogenic clusters and associated functions were identified. Cluster 1, which included beta-catenin and Ras, showed a positive correlation with the cell cycle, while cluster 2, which included TGF-beta, cytokeratin 19 and EpCAM was inversely correlated with immune function. We also used S-score to identify pathways that are differentially expressed in CAC and hepatocellular carcinoma (HCC), the more common subtype of liver cancer. Our results demonstrate the utility and effectiveness of -score in assigning functional roles to tumor-associated gene signature sets and in identifying potential therapeutic targets for specific liver cancer subtypes.

摘要

通过基于微阵列的转录谱从基因特征集(GSSs)中提取最大信息涉及为上调和下调基因赋予功能。在此,我们提出一种名为特征分数(S分数)的新型样本评分方法,该方法可用于量化来自先前确定的基因特征集的肿瘤样本的表达模式。模拟结果表明,与其他评分方法相比,S分数方法具有更高的准确性和稳健性。通过将S分数方法应用于胆管癌(CAC),一种由胆管细胞产生的侵袭性肝癌,我们在两个大型CAC数据集中确定了富集的致癌途径。与正常肝脏和胆管相比,CAC中有13条途径富集。此外,使用S分数,我们能够剖析CAC相关致癌途径与基因本体功能之间的相关性。确定了两个主要的致癌簇及其相关功能。包含β-连环蛋白和Ras的簇1与细胞周期呈正相关,而包含转化生长因子-β、细胞角蛋白19和上皮细胞黏附分子的簇2与免疫功能呈负相关。我们还使用S分数来识别在CAC和肝癌更常见的亚型肝细胞癌(HCC)中差异表达的途径。我们的结果证明了S分数在为肿瘤相关基因特征集赋予功能角色以及识别特定肝癌亚型潜在治疗靶点方面的实用性和有效性。

相似文献

1
Utilizing -score to identify oncogenic pathways of cholangiocarcinoma.利用-评分来识别胆管癌的致癌途径。 需注意,这里原文中的“-score”表述不太完整准确,可能是有具体的评分名称未完整给出。
Transl Cancer Res. 2013 Feb 1;2(1):6-17. doi: 10.3978/j.issn.2218-676X.2012.12.04.
2
Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis.通过整合微阵列分析对肝内胆管癌、肝细胞癌及肝细胞胆管癌联合样本的差异表达基因谱分析
Tumour Biol. 2015 Aug;36(8):5891-9. doi: 10.1007/s13277-015-3261-1. Epub 2015 Feb 26.
3
Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.小鼠肝细胞中转化生长因子-β基因表达特征可预测人类癌症的临床结局。
Hepatology. 2008 Jun;47(6):2059-67. doi: 10.1002/hep.22283.
4
A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.基于 RNA-Seq 数据的新型三 miRNA 标志物预测胆管癌患者的生存情况。
Oncol Rep. 2018 Sep;40(3):1422-1434. doi: 10.3892/or.2018.6534. Epub 2018 Jun 27.
5
EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.上皮细胞黏附分子(EpCAM)和甲胎蛋白表达定义了肝细胞癌新的预后亚型。
Cancer Res. 2008 Mar 1;68(5):1451-61. doi: 10.1158/0008-5472.CAN-07-6013.
6
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.核苷酸还原酶小亚基 M2 是侵袭性前列腺癌的主要驱动因素。
Mol Oncol. 2020 Aug;14(8):1881-1897. doi: 10.1002/1878-0261.12706. Epub 2020 May 31.
7
AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.AXIN 缺失在人类和小鼠肝细胞中诱导肝癌的发生,而无需 β-连环蛋白的激活。
J Hepatol. 2018 Jun;68(6):1203-1213. doi: 10.1016/j.jhep.2017.12.018. Epub 2018 Mar 7.
8
Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma.基因表达谱的荟萃分析确定了肝细胞癌和胆管癌的差异生物标志物。
Tumour Biol. 2016 Sep;37(9):12755-12766. doi: 10.1007/s13277-016-5186-8. Epub 2016 Jul 22.
9
Identification of a novel microRNA signature associated with intrahepatic cholangiocarcinoma (ICC) patient prognosis.与肝内胆管癌(ICC)患者预后相关的新型微小RNA特征的鉴定。
BMC Cancer. 2015 Feb 18;15:64. doi: 10.1186/s12885-015-1067-6.
10
The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.通过高通量数据的生物信息学分析鉴定肝细胞癌中的关键基因和信号通路。
Med Oncol. 2017 Jun;34(6):101. doi: 10.1007/s12032-017-0963-9. Epub 2017 Apr 21.

引用本文的文献

1
Genomic Biomarker Discovery in Disease Progression and Therapy Response in Bladder Cancer Utilizing Machine Learning.利用机器学习发现膀胱癌疾病进展和治疗反应中的基因组生物标志物
Cancers (Basel). 2023 Sep 29;15(19):4801. doi: 10.3390/cancers15194801.
2
Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity.MLL4 缺失导致增强子失活,引发 dsRNA-干扰素信号和 GSDMD 介导的细胞焦亡,增强抗肿瘤免疫。
Nat Commun. 2022 Nov 2;13(1):6578. doi: 10.1038/s41467-022-34253-1.
3
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.

本文引用的文献

1
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma.原发性肝癌发病机制中是否存在共同因素?肝内胆管癌危险因素的荟萃分析。
J Hepatol. 2012 Jul;57(1):69-76. doi: 10.1016/j.jhep.2012.02.022. Epub 2012 Mar 13.
2
Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia.胆管癌的生存分析:马来西亚 10 年经验。
World J Gastroenterol. 2012 Feb 7;18(5):458-65. doi: 10.3748/wjg.v18.i5.458.
3
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
SIX1 将肌源性转录因子重新编程以维持横纹肌肉瘤的未分化状态。
Cell Rep. 2022 Feb 1;38(5):110323. doi: 10.1016/j.celrep.2022.110323.
4
A simple gene set-based method accurately predicts the synergy of drug pairs.一种基于简单基因集的方法能够准确预测药物对的协同作用。
BMC Syst Biol. 2016 Aug 26;10 Suppl 3(Suppl 3):66. doi: 10.1186/s12918-016-0310-3.
5
Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers.差异网络分析揭示了激素性癌症中雌激素受体调控的全基因组图谱。
Sci Rep. 2016 Mar 14;6:23035. doi: 10.1038/srep23035.
6
Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome.缺氧诱导因子 TAp73 通过调节血管生成转录组支持肿瘤发生。
Nat Cell Biol. 2015 Apr;17(4):511-23. doi: 10.1038/ncb3130. Epub 2015 Mar 16.
胆管癌的基因组和遗传学特征鉴定出酪氨酸激酶抑制剂的治疗靶点。
Gastroenterology. 2012 Apr;142(4):1021-1031.e15. doi: 10.1053/j.gastro.2011.12.005. Epub 2011 Dec 13.
4
Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting.在肝癌发生过程中,相邻正常组织中的预测基因优先被 sCNV 改变,这可能是限制因素。
PLoS One. 2011;6(7):e20090. doi: 10.1371/journal.pone.0020090. Epub 2011 Jul 5.
5
Molecular mechanisms of cholangiocarcinoma.胆管癌的分子机制
World J Gastrointest Pathophysiol. 2010 Apr 15;1(1):12-22. doi: 10.4291/wjgp.v1.i1.12.
6
Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.多机构Ⅱ期研究塞来替尼治疗转移性胆道癌患者。
J Clin Oncol. 2011 Jun 10;29(17):2357-63. doi: 10.1200/JCO.2010.33.9473. Epub 2011 Apr 25.
7
Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma.未分化多形性肉瘤与胚胎性横纹肌肉瘤之间意外关系的证据。
Cancer Cell. 2011 Feb 15;19(2):177-91. doi: 10.1016/j.ccr.2010.12.023.
8
Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma.在肝细胞癌中鉴定出胆管癌样基因表达特征。
Cancer Res. 2010 Apr 15;70(8):3034-41. doi: 10.1158/0008-5472.CAN-09-2823.
9
A pathway-based classification of human breast cancer.基于通路的人类乳腺癌分类。
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6994-9. doi: 10.1073/pnas.0912708107. Epub 2010 Mar 24.
10
Progenitor-derived hepatocellular carcinoma model in the rat.大鼠原代肝细胞肝癌模型。
Hepatology. 2010 Apr;51(4):1401-9. doi: 10.1002/hep.23488.